[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA200904323B - DR6 antibodies inhibiting the binding of DR6 to APP, and uses thereof in treating neurological disorders - Google Patents

DR6 antibodies inhibiting the binding of DR6 to APP, and uses thereof in treating neurological disorders

Info

Publication number
ZA200904323B
ZA200904323B ZA200904323A ZA200904323A ZA200904323B ZA 200904323 B ZA200904323 B ZA 200904323B ZA 200904323 A ZA200904323 A ZA 200904323A ZA 200904323 A ZA200904323 A ZA 200904323A ZA 200904323 B ZA200904323 B ZA 200904323B
Authority
ZA
South Africa
Prior art keywords
app
binding
neurological disorders
treating neurological
antibodies inhibiting
Prior art date
Application number
ZA200904323A
Inventor
Anatoly Nikolaev
Marc Tessier-Lavigne
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA200904323B publication Critical patent/ZA200904323B/en

Links

ZA200904323A 2006-12-22 2007-12-21 DR6 antibodies inhibiting the binding of DR6 to APP, and uses thereof in treating neurological disorders ZA200904323B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87152806P 2006-12-22 2006-12-22

Publications (1)

Publication Number Publication Date
ZA200904323B true ZA200904323B (en) 2010-08-25

Family

ID=41495884

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904323A ZA200904323B (en) 2006-12-22 2007-12-21 DR6 antibodies inhibiting the binding of DR6 to APP, and uses thereof in treating neurological disorders

Country Status (2)

Country Link
CN (1) CN101616934A (en)
ZA (1) ZA200904323B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012019902A2 (en) * 2010-02-10 2019-09-24 Novartis Ag "method and compounds for muscle growth"
EP2662387A4 (en) * 2011-01-07 2015-08-05 Seiko Epson Corp Antibody to signal peptide of amyloid precursor protein
BR112017019620A2 (en) * 2015-03-16 2018-05-15 Regeneron Pharmaceuticals, Inc. genetically modified rodent, cell or tissue, methods for producing a genetically modified rodent and motor neuron population, methods for selecting a candidate agent to modulate motor neuronal dysfunction and a candidate agent for reducing oxidative stress in a motor neuron, nucleic acid and rodent cell?
US20220213186A1 (en) * 2019-03-20 2022-07-07 Good T Cells, Inc. Composition for preventing or treating brain and nervous system disease

Also Published As

Publication number Publication date
CN101616934A (en) 2009-12-30

Similar Documents

Publication Publication Date Title
ZA201004219B (en) Dr6 antibodies inhibiting the binding of dr6 to app,and uses thereof in treating neurological disorders
EP2170309A4 (en) Methods and compositions for treating disorders
GB201001047D0 (en) Methods and compositions for the treatment of neurological disorders
WO2009052431A3 (en) Cd19 binding agents and uses thereof
HUE039108T2 (en) Compositions and methods for treating ophthalmic disorders
EP2152266A4 (en) Compositions and methods for treating disorders associated with salt or fluid retention
ZA201001789B (en) Composition and methods for use for antibodies against sclerostin
IL205279A0 (en) Methods of treating urogenital - neurological disorders using modified clostridial toxins
HK1224213A1 (en) Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml) (pml)
HK1101140A1 (en) Compositions and methods for treating neurological disorders
EP2041180A4 (en) Ilt3 binding molecules and uses therefor
EP2083857A4 (en) Methods for treating mica-related disorders
GB2466912B (en) Compositions and methods for treating lysosomal disorders
IL202424A (en) Telomerase activating compounds for use in treating diseases, disorders and conditions related thereto
HK1157575A1 (en) Treating neurological disorders
GB2467710B (en) Methods for treating social disorders
IL205730A0 (en) Methods for treating obesity and obesity related diseases and disorders
EP2205255A4 (en) Herbal compositions and methods for treating hepatitic disorders
HK1118716A1 (en) Method and composition for treating central nervous system disorders
IL193697A0 (en) Methods for treating cognitive and other disorders
EP2120994A4 (en) Methods and compositions for treating hypoglycemic disorders
GB2465814B (en) Method,composition and device for the treatment of enzymes and saccharides disorders
IL196561A0 (en) Compositions and methods for treating diabetes and neuropsychological dysfunction
ZA200904323B (en) DR6 antibodies inhibiting the binding of DR6 to APP, and uses thereof in treating neurological disorders
EP1898921A4 (en) Compositions and methods for treating sleep disorders